An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no additional patient information provided by the customer.This report is being filed on an international product, prism hiv o plus, list 3d34, that has a similar product distributed in the us, list 3l68.
|
Review of complaint activity determined there was normal complaint activity for the prism hiv o plus reagent, lot 90502li00.Tracking and trending report review determined there are no related adverse or non- statistical trends.The performance of the likely cause lot was investigated, and no issues were identified.A retained reagent kit of lot 90502li00 was calibrated, and the calibration met instrument specifications; all control values met control specifications and were in range.A negative human population panel (106 samples) were tested and no false reactive results were obtained.Labeling was reviewed and sufficiently addresses the customer's issue.Based on the investigation, no systemic issue or deficiency was identified for the prism hiv o plus reagent, lot 90502li00.
|